https://www.win-vascularinsightnautilus.com/editorial-3/2023-01-20T20:20:53+02:00https://www.win-vascularinsightnautilus.com/cvd-in-diabetic-patients/2022-12-22T18:07:29+02:00https://www.win-vascularinsightnautilus.com/vvs-development-and-progression-new-insights/2023-01-23T15:35:35+02:00https://www.win-vascularinsightnautilus.com/lymphatics-and-lymphedema-new-insights/2023-02-20T15:43:06+02:00https://www.win-vascularinsightnautilus.com/peri-procedural-complications-in-phlebology/2023-02-23T15:20:19+02:00https://www.win-vascularinsightnautilus.com/multi-specialty-peri-procedural-thrombotic-risk-assessment/2023-03-03T19:12:44+02:00https://www.win-vascularinsightnautilus.com/lead-patients-and-diabetes/2022-12-20T12:29:11+02:00https://www.win-vascularinsightnautilus.com/risk-assessment-for-clinical-decision/2022-12-20T10:20:18+02:00https://www.win-vascularinsightnautilus.com/conservative-treatment-of-lead/2022-12-20T10:23:21+02:00https://www.win-vascularinsightnautilus.com/clinical-and-surgical-management-of-patients-with-chronic-limb-threatening-ischemia/2023-01-09T12:53:37+02:00https://www.win-vascularinsightnautilus.com/chronic-venous-disease-a-multi-specialty-journey-into-translational-medicine/2022-12-07T12:59:40+02:00https://www.win-vascularinsightnautilus.com/more-than-varicose-comorbidities-management/2022-12-06T19:07:40+02:00https://www.win-vascularinsightnautilus.com/c6-challenge-solution/2022-12-05T17:04:11+02:00https://www.win-vascularinsightnautilus.com/from-inflammation-to-thrombosis-and-back/2022-12-05T17:05:58+02:00https://www.win-vascularinsightnautilus.com/endothelial-target-next-step/2022-12-05T17:07:06+02:00https://www.win-vascularinsightnautilus.com/glycocalyx-from-the-bench-to-the-venous-bedside-and-back/2022-12-05T17:08:06+02:00https://www.win-vascularinsightnautilus.com/endothelial-targets-associated-with-comorbidities-in-cvd/2022-12-05T17:09:09+02:00https://www.win-vascularinsightnautilus.com/endothelial-targets-in-thrombotic-risk-management/2022-12-05T17:10:09+02:00https://www.win-vascularinsightnautilus.com/pelvic-venous-disorders-pvd-and-thrombotic-risk/2022-11-18T15:32:16+02:00https://www.win-vascularinsightnautilus.com/editorial-2/2022-11-02T16:10:12+02:00https://www.win-vascularinsightnautilus.com/the-diabetic-challenge-in-chronic-venous-disease-and-post-thrombotic-syndrome/2022-10-27T16:12:54+02:00https://www.win-vascularinsightnautilus.com/comorbidities-impact-on-thrombotic-risk-the-netosis-factors/2022-10-27T16:11:54+02:00https://www.win-vascularinsightnautilus.com/long-covid-19-in-venous-disease/2022-10-27T16:16:04+02:00https://www.win-vascularinsightnautilus.com/international-round-table-post-covid-syndrome-tun-end-cov-study/2022-10-19T17:58:45+02:00https://www.win-vascularinsightnautilus.com/sulodexide-alleviates-long-covid-19-symptoms-by-acting-on-the-endothelial-dysfunction/2022-10-19T17:58:56+02:00https://www.win-vascularinsightnautilus.com/alfasigma-workshop-at-the-european-venous-forum-evf-2022/2022-08-02T12:42:24+02:00https://www.win-vascularinsightnautilus.com/international-guidelines-for-the-antithrombotic-treatment-of-covid-19-patients/2022-07-23T19:14:59+02:00https://www.win-vascularinsightnautilus.com/editorial-back-to-the-future/2022-06-22T12:17:57+02:00https://www.win-vascularinsightnautilus.com/from-the-pandemic-difficulties-to-the-better-patient-care-opportunities/2022-10-27T15:58:05+02:00https://www.win-vascularinsightnautilus.com/sulodexide-what-it-is-what-it-does/2022-06-21T22:48:28+02:00https://www.win-vascularinsightnautilus.com/chronic-venous-diseases-and-medical-treatment/2022-06-21T22:49:28+02:00https://www.win-vascularinsightnautilus.com/sulodexide-compression-venous-and-arterial-topics/2022-06-21T22:50:17+02:00https://www.win-vascularinsightnautilus.com/varicose-veins-thrombotic-risk-unmet-needs/2022-06-21T22:51:11+02:00https://www.win-vascularinsightnautilus.com/post-covid-19-era-thrombosis-risk-management-challenges/2022-06-21T22:51:55+02:00https://www.win-vascularinsightnautilus.com/periprocedural-thrombotic-risk-management-unmet-needs/2022-06-21T22:52:42+02:00https://www.win-vascularinsightnautilus.com/from-the-bench-to-the-bedside-and-back/2022-06-10T00:39:24+02:00https://www.win-vascularinsightnautilus.com/pelvic-venous-disorders-and-thrombotic-risk/2022-06-10T00:30:00+02:00https://www.win-vascularinsightnautilus.com/vvs-inflammation-thrombotic-risk-and-arterial-correlations/2022-06-10T00:26:47+02:00https://www.win-vascularinsightnautilus.com/from-bench-to-the-bedside-in-post-thrombotic-syndrome-benefit/2022-06-10T00:22:56+02:00https://www.win-vascularinsightnautilus.com/net-clinical-benefit-in-advance-vascular-cases/2022-06-10T00:19:25+02:00https://www.win-vascularinsightnautilus.com/vein-and-or-lymphatic-interventions-peri-procedural-management/2022-06-10T00:14:50+02:00https://www.win-vascularinsightnautilus.com/editorial/2022-06-09T23:59:44+02:00https://www.win-vascularinsightnautilus.com/similia-similibus-curantur-the-vascular-paradox-of-sars-cov-2-vaccination/2022-06-09T23:56:05+02:00https://www.win-vascularinsightnautilus.com/similia-similibus-curantur-the-vascular-paradox-of-sars-cov-2-vaccination-new-perspective-on-pathophysiology-and-investigation-of-chronic-venous-disease/2022-06-22T09:55:00+02:00https://www.win-vascularinsightnautilus.com/sulodexide-in-the-outpatient-treatment-of-covid-19-a-randomized-controlled-trial/2022-06-09T23:43:26+02:00https://www.win-vascularinsightnautilus.com/challenges-in-the-treatment-of-symptomatic-cvd-patients-in-our-daily-practice/2022-06-09T23:37:03+02:00https://www.win-vascularinsightnautilus.com/accelerate-and-promote-deep-vein-thrombosis-resolution/2022-06-09T23:30:05+02:00https://www.win-vascularinsightnautilus.com/the-discovery-of-a-vaccine-is-among-the-greatest-victories-of-history-of-medicine/2022-06-09T22:49:13+02:00https://www.win-vascularinsightnautilus.com/is-the-sars-cov-2-treatable-at-home/2022-06-22T09:50:16+02:00https://www.win-vascularinsightnautilus.com/thrombosis-and-pelvic-venous-disorders/2022-06-09T12:23:47+02:00https://www.win-vascularinsightnautilus.com/clinical-challenge-of-leg-venous-ulcer-healing/2022-06-09T12:19:35+02:00https://www.win-vascularinsightnautilus.com/caprini-score-in-covid-19-patients/2022-06-09T11:56:10+02:00https://www.win-vascularinsightnautilus.com/recent-meta-analysis-of-randomized-trials-on-sulodexide-and-risk-of-thrombotic-and-hemorrhagic-events/2022-06-09T11:47:42+02:00https://www.win-vascularinsightnautilus.com/myocardial-protection-in-patients-undergoing-cardiac-valve-surgery/2022-06-09T11:42:49+02:00https://www.win-vascularinsightnautilus.com/from-william-ernest-henley-the-hospital-poem-invictus-an-encouragement-against-the-pandemic/2022-06-09T11:24:28+02:00https://www.win-vascularinsightnautilus.com/win-4-2021-editorial/2022-06-22T11:31:06+02:00https://www.win-vascularinsightnautilus.com/net-clinical-benefit-in-venous-diseases/2022-06-22T11:32:43+02:00https://www.win-vascularinsightnautilus.com/patient-risk-profile-in-clinical-management/2022-06-22T11:34:21+02:00https://www.win-vascularinsightnautilus.com/iua-perspective-about-unmet-needs-and-best-practice-in-pad-management/2022-06-22T11:35:25+02:00https://www.win-vascularinsightnautilus.com/esc-guidelines-recent-innovation-and-open-challenges-in-pad-management/2022-06-22T11:36:23+02:00https://www.win-vascularinsightnautilus.com/february-2022-new-2022-esvs-clinical-practice-guidelines/2022-03-02T00:47:49+02:00https://www.win-vascularinsightnautilus.com/gaspare-asellis-serendipity/2022-06-22T11:37:38+02:00https://www.win-vascularinsightnautilus.com/esvs-2022-clinical-practice-guidelines-on-the-management-of-cvd-of-the-lower-limbs-what-is-new/2022-07-25T15:34:39+02:00https://www.win-vascularinsightnautilus.com/padua-prediction-score-for-risk-of-vte/2022-03-17T10:35:33+02:00https://www.win-vascularinsightnautilus.com/vienna-prediction-model-for-recurrent-vte/2022-02-20T02:50:45+02:00https://www.win-vascularinsightnautilus.com/ceap-classification-table/2022-02-20T02:48:28+02:00https://www.win-vascularinsightnautilus.com/january-2022-the-achieve-innovation-2021-is-now-available/2022-02-18T10:33:01+02:00https://www.win-vascularinsightnautilus.com/a-brief-introduction-by-prof-mauro-gargiulo-esvs-president-who-co-chaired-the-symposium-to-number-4-2021/2022-03-02T01:42:50+02:00https://www.win-vascularinsightnautilus.com/december-2021-the-new-number-of-win-vascular-insight-nautilus-is-now-online/2022-02-10T01:03:25+02:00https://www.win-vascularinsightnautilus.com/individual-risk-profile-drive-and-endothelial-target-in-clinical-management-of-vascular-patients-symposium-at-esvs-35th-annual-meeting-in-rotterdam-2021-is-freely-available/2022-03-02T01:45:49+02:00https://www.win-vascularinsightnautilus.com/november-2021-individual-risk-profile-of-vascular-patients-symposium-is-freely-available/2022-02-10T00:46:18+02:00https://www.win-vascularinsightnautilus.com/the-uip-buenos-aires-2021-is-on-demand-dr-oscar-hugo-bottini-presents-the-uip-world-general-council-helded-in-buenos-aires/2022-03-02T01:47:30+02:00https://www.win-vascularinsightnautilus.com/uip-buenos-aires-2021-symposia-net-clinical-benefit-ncb-in-phlebo-lymphology-and-biosignaling-target-in-thrombotic-risk-management/2022-03-02T01:54:51+02:00https://www.win-vascularinsightnautilus.com/november-2021-the-uip-congress-2021-is-available-online/2022-02-10T00:44:32+02:00https://www.win-vascularinsightnautilus.com/take-home-messages-from-symposium-venous-patients-facing-the-current-clinica-challenges/2022-03-02T02:02:12+02:00https://www.win-vascularinsightnautilus.com/september-2021-vascular-insight-nautilus-new-issue-focus-on-european-venous-forum/2022-02-10T00:43:15+02:00https://www.win-vascularinsightnautilus.com/net-clinical-benefit-in-vascular-patients/2022-03-10T02:00:18+02:00https://www.win-vascularinsightnautilus.com/august-2021-net-clinical-benefit-in-vascular-patients/2022-02-10T00:41:40+02:00https://www.win-vascularinsightnautilus.com/free-access-to-workshop-venous-patients-facing-the-current-clinical-challenges-at-evf-virtual-event-2021/2022-03-10T02:02:42+02:00https://www.win-vascularinsightnautilus.com/707/2022-06-09T22:34:22+02:00https://www.win-vascularinsightnautilus.com/july-2021-free-access-to-workshop-venous-patients-facing-the-current-clinical-challenges-at-evf-virtual-event-2021/2022-02-10T00:40:15+02:00https://www.win-vascularinsightnautilus.com/june-2021-the-new-number-of-win-vascular-insight-nautilus-is-online/2022-02-10T00:38:20+02:00https://www.win-vascularinsightnautilus.com/may-2021-first-esvs-guidelines-on-venous-thrombosis/2022-02-10T00:37:01+02:00https://www.win-vascularinsightnautilus.com/esvs-guidelines-on-venous-thrombosis/2022-03-10T02:04:28+02:00https://www.win-vascularinsightnautilus.com/april-2021-does-sulodexide-prevent-the-sars-cov-2-mediated-endothelialitis-with-hypercoagulability-and-inflammation/2022-02-10T00:33:07+02:00https://www.win-vascularinsightnautilus.com/does-sulodexide-prevent-the-sars-cov-2-mediated-endothelialitis-with-hypercoagulability-and-inflammation/2022-03-10T02:06:07+02:00https://www.win-vascularinsightnautilus.com/march-2021-weekly-solv-website-ondemand-is-available-online/2022-02-10T00:31:04+02:00https://www.win-vascularinsightnautilus.com/weekly-solv-website-ondemand-is-available-online/2022-03-10T02:07:30+02:00https://www.win-vascularinsightnautilus.com/march-2021-save-the-date-for-vein-week-from-april-5th-to-11th/2022-02-10T00:29:20+02:00https://www.win-vascularinsightnautilus.com/february-2021-waiting-to-meet-again-at-the-congress-the-new-number-of-win-nautilus-is-online/2022-02-10T00:27:31+02:00https://www.win-vascularinsightnautilus.com/save-the-date-for-vein-week-from-april-5th-to-11th/2022-03-10T02:09:23+02:00https://www.win-vascularinsightnautilus.com/february-2021-iua-2020-extended-access-and-dedicated-win-nautilus-highlights/2022-02-10T00:17:41+02:00https://www.win-vascularinsightnautilus.com/iua2020-extended-access-and-dedicated-win-nautilus-highlights/2022-03-10T02:11:31+02:00https://www.win-vascularinsightnautilus.com/difficulties-in-venous-leg-ulcers-healing/2022-03-10T02:12:52+02:00https://www.win-vascularinsightnautilus.com/january-2021-difficulties-in-venous-leg-ulcers-healing/2022-02-10T00:17:02+02:00https://www.win-vascularinsightnautilus.com/free-access-to-alfasigma-workshop-over-the-standard-treatment-in-vascular-diseases-at-the-esvs-month-annual-meeting/2022-03-10T01:51:27+02:00https://www.win-vascularinsightnautilus.com/903/2022-06-09T22:33:55+02:00https://www.win-vascularinsightnautilus.com/reducing-hyperpigmentation-after-sclerotherapy-using-an-antithrombotic-drug-rhyas-trial-midterm-results/2022-06-09T22:31:06+02:00https://www.win-vascularinsightnautilus.com/nautilus-an-international-vascular-journal/2022-06-09T22:30:04+02:00https://www.win-vascularinsightnautilus.com/aesthetic-phlebology/2022-06-09T22:30:36+02:00https://www.win-vascularinsightnautilus.com/post-thrombotic-syndrome-pts/2022-06-09T22:24:44+02:00https://www.win-vascularinsightnautilus.com/new-isth-score-for-post-thrombotic-syndrome-pts/2022-06-09T22:29:22+02:00https://www.win-vascularinsightnautilus.com/post-thrombotic-syndrome-pts-predictors/2022-06-09T22:28:31+02:00